Trial Profile
A Long-Term Follow-up study evaluating prognostic biomarkers in lentigo maligna patients treated with imiquimod cream
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 02 Dec 2015 New trial record
- 22 Oct 2015 Results published in the Journal of the American Academy of Dermatology